Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Sep;14(3):384–390. doi: 10.1128/aac.14.3.384

Susceptibility of Anaerobic Bacteria to Sulfamethoxazole/Trimethoprim and Routine Susceptibility Testing

Jürg Wüst 1, Tracy D Wilkins 2
PMCID: PMC352469  PMID: 708016

Abstract

The minimal inhibitory concentrations (MICs) of sulfamethoxazole and trimethoprim against 144 strains of obligately anaerobic bacteria were determined on Diagnostic Sensitivity Test agar (Oxoid) or in prereduced Diagnostic Sensitivity Test broth, both supplemented with sodium pyruvate (1 mg/ml), hemin (5 μg/ml), and vitamin K1 (1 μg/ml). Fifty-eight percent of the strains were susceptible to sulfamethoxazole alone (MIC ≤ 16 μg/ml), only 12% were susceptible to trimethoprim alone (MIC ≤ 1 μg/ml), and 85% were susceptible to the combination of sulfamethoxazole plus trimethoprim (MIC ≤ 16 μg/ml) at a ratio of 19:1. All 45 strains of the Bacteroides fragilis group were susceptible to the combination. Synergy of the combination was often observed by a checkerboard MIC determination of 123 strains, usually most markedly when the ratio of the two components was near 1:1. However, there was also synergism at the ratio of sulfamethoxazole to trimethoprim of 16:1 in 61 (53.5%) of the 114 strains that could be evaluated for synergistic activity. When the strains were tested by the broth-disk test proposed by Wilkins and Thiel, modified by using prereduced Diagnostic Sensitivity Test broth instead of brain heart infusion broth and by using a smaller inoculum, there was over 90% correlation with the MICs. Poor results were found when the broth-disk tests were performed in brain heart infusion broth. There was very poor correlation between inhibition zone diameters by an agar diffusion method and MICs.

Full text

PDF
384

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blazevic D. J. Evaluation of the modified broth-disk method for determining antibiotic susceptibilities of anaerobic bacteria. Antimicrob Agents Chemother. 1975 Jun;7(6):721–723. doi: 10.1128/aac.7.6.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Darrell J. H., Garrod L. P., Waterworth P. M. Trimethoprim: laboratory and clinical studies. J Clin Pathol. 1968 Mar;21(2):202–209. doi: 10.1136/jcp.21.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dornbusch K., Nord C. E., Wadström T. Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. Scand J Infect Dis. 1974;6(3):253–258. doi: 10.3109/inf.1974.6.issue-3.08. [DOI] [PubMed] [Google Scholar]
  4. ELION G. B., SINGER S., HITCHINGS G. H. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J Biol Chem. 1954 Jun;208(2):477–488. [PubMed] [Google Scholar]
  5. Ferone R., Bushby S. R., Burchall J. J., Moore W. D., Smith D. Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines. Antimicrob Agents Chemother. 1975 Jan;7(1):91–98. doi: 10.1128/aac.7.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Garrod L. P., Waterworth P. M. A study of antibiotic sensitivity testing with proposals for simple uniform methods. J Clin Pathol. 1971 Dec;24(9):779–789. doi: 10.1136/jcp.24.9.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hanson G. C., Woods R. L. Intravenous trimethoprim/sulphadimidine in the treatment of Bacteroides septicaemia. Postgrad Med J. 1975 Feb;51(592):105–106. doi: 10.1136/pgmj.51.592.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Holdeman L. V., Good I. J., Moore W. E. Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol. 1976 Mar;31(3):359–375. doi: 10.1128/aem.31.3.359-375.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kayser F. H., Wüst J. Determination of bacterial resistance to trimethoprim-sulphamethoxazole using the single disc diffusion method. Chemotherapy. 1973;18(3):162–168. doi: 10.1159/000221258. [DOI] [PubMed] [Google Scholar]
  10. Kerry D. W., Hamilton-Miller J. M., Brumfitt W. Trimethoprim and rifampicin: in vitro activities separately and in combination. J Antimicrob Chemother. 1975 Dec;1(4):417–427. doi: 10.1093/jac/1.4.417. [DOI] [PubMed] [Google Scholar]
  11. Moore W. E., Holdeman L. V. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol. 1974 May;27(5):961–979. doi: 10.1128/am.27.5.961-979.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Näff H. Uber die Veränderungen der normalen Darmflora des Menschen durch Bactrim. Pathol Microbiol (Basel) 1971;37(1):1–22. [PubMed] [Google Scholar]
  13. Okubadejo O. A., Green P. J., Payne D. J. Bacteroides in the blood. Lancet. 1973 Jan 20;1(7795):147–147. [PubMed] [Google Scholar]
  14. Okubadejo O. A. Letter: Susceptibility of Bacteroides fragilis to co-trimoxazole. Lancet. 1974 May 25;1(7865):1061–1061. doi: 10.1016/s0140-6736(74)90471-1. [DOI] [PubMed] [Google Scholar]
  15. Phillips I., Warren C. Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis. Antimicrob Agents Chemother. 1976 May;9(5):736–740. doi: 10.1128/aac.9.5.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rosenblatt J. E., Stewart P. R. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria. Antimicrob Agents Chemother. 1974 Jul;6(1):93–97. doi: 10.1128/aac.6.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schoutens E., Labbé M., Yourassowsky E. Septicémies à Bacteroïdes fragilis. Incidence et sensibilité des souches aux antibiotiques. Pathol Biol (Paris) 1973 Apr;21(4):349–353. [PubMed] [Google Scholar]
  18. Sutter V. L., Finegold S. M. The effect of antimicrobial agents on human faecal flora: studies with cephalexin, cyclacillin and clindamycin. Soc Appl Bacteriol Symp Ser. 1974;3(0):229–240. [PubMed] [Google Scholar]
  19. Whitman E. N. Effects in man of prolonged administration of trimethoprim and sulfisoxazole. Postgrad Med J. 1969 Nov;45(Suppl):46–51. [PubMed] [Google Scholar]
  20. Wilkins T. D., Chalgren S. Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother. 1976 Dec;10(6):926–928. doi: 10.1128/aac.10.6.926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wilkins T. D., Thiel T. Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria. Antimicrob Agents Chemother. 1973 Mar;3(3):350–356. doi: 10.1128/aac.3.3.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Yourassowsky E., Vanderlinden M. P., Schoutens E. Sensitivity of Streptococcus pyogenes to sulphamethoxazole, trimethoprim, and cotrimoxazole. J Clin Pathol. 1974 Nov;27(11):897–901. doi: 10.1136/jcp.27.11.897. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES